DSP-7888 is an investigational cancer vaccine containing two peptides that induce WT1-specific cytotoxic T lymphocytes and helper cells to attack WT1-expressing cancerous cells found in various types of hematologic malignancies and solid tumors. Researchers have found that adding helper T-cell-inducing peptides, improved outcomes may be achieved compared with a treatment regimen that induced only WT1-CTL's.
#cancer therapy DSP-7888 #cancer cell apotheosis #T- cell #cytotoxic lymphoma
Keywords: 3D, Education, Professional Education, Disease Management, Pharmacology, Oncology
© Jackie Heda